A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

SL Rogers, MR Farlow, RS Doody, R Mohs… - Neurology, 1998 - AAN Enterprises
The efficacy and safety of donepezil as a treatment for patients with mild to moderate
Alzheimer's disease (AD) was investigated in a multicenter, double-blind study. Patients …
被引用次数：2185 相关文章

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

SL Rogers, MR Farlow, RS Doody, R Mohs… - …, 1998 - pubmed.ncbi.nlm.nih.gov
The efficacy and safety of donepezil as a treatment for patients with mild to moderate
Alzheimer's disease (AD) was investigated in a multicenter, double-blind study. Patients …
[PDF] stfx.ca

[PDF][PDF] A 24= week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

SL Rogers, MR Farlow, RS Doody, R Mohs… - …, 1998 - people.stfx.ca
Article abstract-The efficacy and safety of donepezil as a treatment for patients with mild to
moderate Alzheimer's disease (AD) was investigated in a multicenter, double-blind study …

[引用][C] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

SL ROGERS, MR FARLOW, RS DOODY, R MOHS… - …, 1998 - pascal-francis.inist.fr
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's
disease CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

SL Rogers, MR Farlow, RS Doody, R Mohs… - Neurology, 1998 - europepmc.org
The efficacy and safety of donepezil as a treatment for patients with mild to moderate
Alzheimer's disease (AD) was investigated in a multicenter, double-blind study. Patients …

[引用][C] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

SL Rogers, MR Farlow, RS Doody, R Mohs… - Neurology, 1998 - cir.nii.ac.jp
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's
disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

A 24-wk, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease.

SL Rogers, MR Farlow, RS Doody, R Mohs… - Neurology, 1998 - psycnet.apa.org
Investigated the efficacy and safety of donepezil as a treatment for patients with mild to
moderate Alzheimer's disease (AD) in a multicenter, double-blind study. Ss were randomly …

[引用][C] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

R SL - Neurology, 1998 - cir.nii.ac.jp
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's
disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

[引用][C] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

SL ROGERS, MR FARLOW, RS DOODY… - …, 1998 - Lippincott Williams & Wilkins